Beam Therapeutics Inc.

BEAM · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances)
107
SEC Filings

Business Summary

PART I Item 1. B usiness. Overview We are a biotechnology company committed to establishing the leading, fully integrated platform for precision genetic medicines. Our vision is to provide life-long cures to patients suffering from serious diseases. To achieve this vision, we have assembled a platform that includes a suite of gene editing and delivery technologies as well as internal manufacturing capabilities. Our suite of gene editing technologies is anchored by our proprietary base editing te...

Next Earnings

Q2 FY2026 — expected 2026-08-03

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionBEAMdiscussed_in_filing Cybersecurity
topic_mentionBEAMdiscussed_in_filing Cybersecurity
topic_mentionBEAMdiscussed_in_filing Platform & Ecosystem
topic_mentionBEAMdiscussed_in_filing Platform & Ecosystem

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-242025-12-310001193125-26-065194EDGAR141K words
2025-02-252024-12-310000950170-25-026076EDGAR—
2024-02-272023-12-310000950170-24-020622EDGAR—
2023-02-282022-12-310000950170-23-004866EDGAR—
2022-02-282021-12-310000950170-22-002166EDGAR—
2021-03-152020-12-310001564590-21-013190EDGAR—
2020-03-302019-12-310001564590-20-014308EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-042025-09-300001193125-25-263542EDGAR35K words
2025-08-052025-06-300000950170-25-102393EDGAR—
2025-05-062025-03-310000950170-25-063966EDGAR—
2024-11-052024-09-300000950170-24-121104EDGAR—
2024-08-062024-06-300000950170-24-091242EDGAR—
2024-05-072024-03-310000950170-24-053939EDGAR—
2023-11-082023-09-300000950170-23-060683EDGAR—
2023-08-082023-06-300000950170-23-039364EDGAR—
2023-05-102023-03-310000950170-23-020090EDGAR—
2022-11-072022-09-300000950170-22-022322EDGAR—
2022-08-092022-06-300000950170-22-015755EDGAR—
2022-05-092022-03-310000950170-22-008238EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-050001193125-26-093914EDGAR1K words
2026-02-240001193125-26-065191EDGAR—
2026-02-120001193125-26-048684EDGAR—
2026-02-050001193125-26-039365EDGAR—
2026-01-120001193125-26-009722EDGAR—
2025-12-110001193125-25-316043EDGAR—
2025-11-040001193125-25-263536EDGAR—
2025-08-050000950170-25-102389EDGAR—
2025-07-030000950170-25-093906EDGAR—
2025-06-060000950170-25-083043EDGAR—

107 total filings indexed. 78 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0001745999
TickerBEAM
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: b19fb999dff86c0af3e2522fbb74481717f30a3c72ef922ee5c1d21915cf4a20
parent: e637e4fce82553fe4690ddbdc39258ac784fa843e234af2acac0118cbdf1b765
content hash: c8977b10ebc4a536a1cb62f305bd806a3d3fee2cf16f1dbaffdb4ec4d966a1f7
signed: 2026-04-13T04:43:55.498Z
sources: 19 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf